Open for Enrollment

Pediatrics

Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Apixaban in Pediatric Subjects with an Indwelling Central Venous. Protocol # CV185079

A Phase 3, Open-Label, Multi-center study of the safety, Pharmacokinetics, and efficacy of Buprenorphine Transdermal (BTDS) in Opioid-Naive and/opr Opioid-Tolerant children from 7 to 16 years of age, inclusive, who require continuous Opioid Analgesia.